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Background: Although heterogeneity of depression hinders research and clinical 
practice, attempts to reduce it with latent variable models have yielded 
inconsistent results, probably because these techniques cannot account for all 
interacting sources of heterogeneity at the same time.  
 
 
Methods: To simultaneously decompose depression heterogeneity on the person-, 
symptom and time-level, three-mode Principal Component Analysis (3MPCA) 
was applied to data of 219 Major Depression patients, who provided Beck 
Depression Inventory assessments every three months for two years. The resulting 
person-level components were correlated with external baseline clinical and 
demographic variables.  
 
 
Results: The 3MPCA extracted two symptom-level components (‘cognitive’, 
‘somatic-affective’), two time-level components (‘improving’, ‘persisting’) and 
three person-level components, characterized by different interaction-patterns 
between the symptom- and time-components (‘severe non-persisting’, ‘somatic 
depression’ and ‘cognitive depression’). This model explained 28% of the total 
variance and 65% when also incorporating the general trend in the data). 
Correlations with external variables illustrated the content differentiation between 
the person-components. Severe non-persisting depression was positively 
correlated with psychopathology (r=0.60) and negatively with quality of life (r=-
0.50). Somatic depression was negatively correlated with physical functioning 
(r=-0.45). Cognitive depression was positively correlated with neuroticism 
(r=0.38) and negatively with self-esteem (r=-0.47).  
 
 
Conclusions: 3MPCA decomposes depression into homogeneous entities, while 
accounting for the interactions between different sources of heterogeneity, which 
shows the utility of the technique to investigate the underlying structure of 
complex psychopathology data and could help future development of better 








The heterogeneity of Major Depressive Disorder (MDD) is one of the great 
challenges in psychiatry [1]. Patients with MDD vary in terms of severity, age of 
onset, duration, recurrence and symptom profiles [2, 3]. Unfortunately, the 
identification of replicable, more homogeneous diagnostic entities has proven to 
be difficult [4-7]. 
Two main approaches have been taken to identify more homogeneous 
entities of depression, using either ‘clinical categories’ or ‘data driven’ 
approaches. The former approach uses a priori combinations of symptoms, course 
trajectories (e.g. chronic, recurrent) and/or severity, which are anchored in clinical 
theories or experience, to differentiate between patients [7]. This approach may 
increase reliability and improve communication between practitioners, but studies 
of a priori depression subtypes have yielded inconsistent results with respect to 
their clinical characteristics, etiology and correlations with external factors [7, 8]. 
Data-driven approaches have also been widely used, both on the person level (e.g. 
subtypes) and on the symptom-level (e.g. symptom subdomains). For instance, 
Latent Class Analysis (LCA) has been used to identify more homogeneous groups 
of patients [9,10] and Principal Component Analysis (PCA) and Factor Analysis 
(FA) have been used to identify more homogeneous subdomains (dimensions) 
underlying depression [11-16]. All of this work suggests that depression can be 
decomposed into more specific entities. However, the results have been 
inconsistent, in part due to the diversity in study designs, samples, analytical 
methods and input-variables [17].  
To date, data-driven approaches of depression heterogeneity have only 
taken into account one or two sources of heterogeneity at the same time. At a 
maximum, these approaches considered two modes of the data, the person- and 
symptom-modes. For example, LCA yields person-classes, while assuming no 
heterogeneity over time. On the other hand, FA subdivides a set of symptoms into 
more homogeneous factors, but rests on the assumption that there is no latent 
population heterogeneity [18]. Work to integrate the two approaches (LCA and 
FA) has, for example, resulted in factor mixture models that assume different 
factor model parameters across latent classes [18]. However, even when 
integrated, neither person- nor symptom-based latent variable solutions 
incorporate the temporal structure of depression, while temporal course in fact is 
considered an important clinical discriminator (e.g. remission vs. chronicity) [19]. 
It is possible to define person-groups based on latent patterns of change over time 
by using latent class growth analysis (LCGA), Growth Mixture Modeling (GMM) 
[20] and latent transition analysis (LTA) [21]. However, these techniques require 
a priori input on the latent structure of the symptom domain(s) upon which change 
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is modeled [22]. In addition, when using all abovementioned techniques, 
empirical interactions between different sources of heterogeneity remain 
undetected as symptom-, person- and time-mode heterogeneity are modeled 
separately. 
 Incorporating person-, symptom- and time-mode data in a single analysis 
is possible if the data can be arranged in a three-way array or ‘data cube’ [23]. 
Such data pertain to measurements of various symptoms (symptom-mode) in a 
number of persons (person-mode) at various time points (time-mode). To decrease 
heterogeneity, multimode techniques, such as Three-mode Principal Component 
Analysis (3MPCA) [24, 25], also referred to as Tucker 3 analysis [26], Three-
mode factor analysis [27, 28] or Three-way Component Analysis [29] can be 
applied. 3MPCA is a statistical technique, which summarizes person-, symptom- 
and time point heterogeneity with a parsimonious number of components [26, 30, 
31]. The aim of the current study was to use 3MPCA to capture the heterogeneity 
of depression in a single model and to interpret the results in depth by looking at 
the correlations of the person-components with external variables. To this end, 
3MPCA was applied to a longitudinal dataset, consisting of MDD patients 
(N=219) who were administered the Beck Depression Inventory (BDI) [32] at 3-




Participants and procedures 
The data used for this study came from a randomized-controlled trial (RCT) in 
primary care MDD patients. The inclusion-strategy and data-collection procedure 
have been described in detail elsewhere [33] and are summarized below. Although 
the sample came from an RCT, it was treated as a whole since previous work [34] 
suggested that there was no difference between treatment conditions in terms of 
depression course. 
Three-hundred-ninety-seven participants were referred by 49 GP-
practices in the North of the Netherlands. Inclusion criteria for the study were: 
having a history of depression, no presence of a life-threatening somatic disease 
and no current psychotherapy. Exclusion criteria were: pregnancy, the presence 
of dementia, a bipolar disorder, a psychotic disorder and/or a primary diagnosis 
of alcohol or drug dependence. The referred patients were interviewed with the 
Composite International Diagnostic Interview (CIDI) [35, 36] to confirm the 
presence of a major depressive episode and absence of other psychopathology. 




the study resulting in a sample of 267 patients (67.3%). The study protocol was 
approved by the medical ethical committee of the University Medical Center 
Groningen. All participants signed informed consent. 
Measures 
The BDI was administered at baseline and at each 3-monthly follow-up during 
the two year study period. The following baseline demographic characteristics 
were documented: age, gender, income, education level and working status. Also, 
several questionnaires were administered at baseline: the Medical Outcomes 
Study 36-item Short Form (SF-36) [37], the Symptoms Checklist-90 (SCL-90) 
[38], the Neuroticism-Extraversion-Openness-Five-Factor Inventory (NEO-FFI) 






The statistical analyses consisted of nine steps.  (1) The sample was selected based 
on the extent of missing data. (2) Multiple imputation was used to impute missing 
BDI responses. (3) A three-way ANOVA was conducted with the imputed data. 
(4) The data were preprocessed. (5) 3MPCA model complexity was selected. (6) 
The 3MPCA model was fit to each of the imputed datasets. (7) The obtained 
components were rotated using Generalized Procrustes rotation. (8)  The 
explained variance of the 3MPCA models was computed. (9) The components 
and their interactions were interpreted. 
 
(1) Sample selection 
Patients who provided data on at least 5 out of 9 measurement time points were 
included in the analysis. Eventually, 219 (82%) out of 267 patients were included 
in the current analysis. Details about the inclusion procedure can be found in the 
Appendix A. 
 
(2) Multiple imputation 
Missing values occurred in 7.8% of BDI scores and were imputed 20 times using 
the Amelia II [42] R-package running in RStudio (R version 3.0.0). Demographics 
collected at baseline and scores on the abovementioned questionnaires and BDI 
scores collected from the baseline up to three-year follow-up were included in the 
imputation model. Details of the imputation procedure are presented in the 
Appendix B. 
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(3) Three-way ANOVA  
The percentages of explained variance by the main effects (persons, symptom-
responses, and time-points) and by all pairwise interactions were estimated from 
a fixed-effects three-way analysis of variance (ANOVA). This analysis was 
conducted in each of the 20 imputed datasets after subtraction of the grand mean 
[26] to confirm whether the dataset contained a non-negligible three-way 
interaction between the person-, symptom- and time-mode.   
 
(4) Data preprocessing 
Before 3MPCA was applied to each of the imputed datasets, each imputed dataset 
was preprocessed. In the current analysis, each of the imputed datasets was first 
centered across the person-mode and then normalized within symptom mode. A 
detailed description of the data preprocessing procedure is given in the Appendix 
C. 
By centering across person-mode, the average scores on all symptoms at all 
times are removed from the data, so that the 3MPCA results apply to the 
deviations from the average scores, or more formally, to the variations that occur 
around the mean trend in the dataset. This ensures that the 3MPCA models 
qualitative heterogeneity (e.g. trajectory differences), rather than merely 
quantitative heterogeneity (e.g. severity differences). Some examples of this 
‘average person’s response’ are shown in Figure 1.A. 
By normalizing within symptom-mode, all BDI items were treated as equally 
important in the model. This is important because when variables have 
considerably differing variances, the one with the largest variance will influence 
the 3MPCA solution more than the ones with smaller variances [26, 31]. This 
undesirable effect was avoided by the applied normalization. 
 
(5) Selection of 3MPCA model complexity 
After the imputed data were preprocessed, 3MPCA was used to extract a solution 
for the current three-way data with a small number of components for patients 
(person-mode), BDI symptom-items (symptom-mode), and time-points (time-
mode). To guide the selection of the number of components for each mode, the 
generalized scree test [43, 44] was applied. Stability of the solution was tested by 
comparison of 3MPCA solutions across the 20 imputed datasets and by use of 
split-half procedures in each dataset.  
 
(6) 3MPCA model fitting  
For the selected 3MPCA model complexity, it was desirable to obtain simple 




array in order to generate clinically interpretable results on the person-level. This 
was attained by an orthogonal rotation procedure called Joint Orthomax [45]. 
Standard weights [45] were selected for the current analysis, but no weights were 
assigned for the person-mode.  
 
(7) Generalized Procrustes rotation 
By following abovementioned steps, 20 estimated component structures were 
generated (a 3MPCA in each imputed dataset). The resulting component estimates 
were then combined in one person-, symptom- and time-mode and the core array 
by applying generalized Procrustes rotation [31, 46, 47], which calculates the 
average of each component and core array. 
 
(8) Computation of  explained variance 
Two types of fit percentages were calculated for the estimated array obtained from 
the averaged components and the core array. First, the fit percentage of the 
estimated array was calculated for each of the 20 imputed datasets. This fit 
percentage reflected the heterogeneity part of the variance in the data, capturing 
the variance around the general trend in the data. Second, the overall fit 
percentage of the estimated array was calculated after incorporating the general 
trend (details in S4 Appendix). This fit percentage reflects the 3MPCA model’s 
total explained variance, consisting of the general trend part (rescaled item mean 
scores for each time point) and the heterogeneity part. These two types of fit 
percentages can be a measure to judge the ability of the model to explain the 
variance in the data, rather than as a test of good model-fit. More details on the 
interpretation of the fit percentage is given in the Appendix D. 
 
(9) Interpretation of the components 
To gain insight in the characteristics of the identified person-mode components, 
correlations with external measures were calculated. Depending on the 
distribution of the variables, Spearman or Pearson correlations were calculated. 
All analyses, except for the multiple imputations were performed with Matlab 
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Of the participants, 65.8% was female and the mean age was 43.3 years 
(s.d.=11.1). The mean score on the SCL-90 depression scale was 42.5 (s.d.=12.5) 
and the mean SCL-90 anxiety scale score was 21.8 (s.d.=7.8). The mean baseline 
BDI score was 19.5 (s.d.=9.1) indicating moderate depression severity [48].  The 
mean BDI scores decreased considerably at first, stabilizing over time. However, 
there was considerable variability in the individual BDI-score trajectories (see 
Figure 1.B).  
Three-way ANOVA 
Results of the fixed-effects three-way ANOVA, averaged across the 20 imputed 
samples, are presented in Table 1. The highest percentages of explained variance 
were seen for the two-way persons-by-symptoms interaction, the main effect of 
persons and the three-way-interaction-plus-error term. The latter effect had the 
largest contribution indicating the importance of interactions between the person-, 
symptom- and time-modes and underlining the usefulness of fitting a 3MPCA 
model that allows for the modeling of such interactions. Small standard deviations 




Table 1. Three-way Analysis of Variance after subtraction of the grand mean, 
with the patient-, symptom- and time-components as fixed factors. 
Note. SS= Sum of Squares. All effects and standard deviations (s.d.) averaged 
across 20 imputed datasets. 
 
Effect 
Sum of squares 
(s.d.) 
% of explained 
variance (s.d.) 
Persons 4950 (48.5) 20.0 (0.17) 
Symptoms 2296 (17.7) 9.3 (0.07) 
Time 894 (14.1) 3.6 (0.06) 
Persons * Symptoms 6056 (19.2) 24.5 (0.06) 
Persons * Time 2273 (30.4) 9.2 (0.12) 
Symptoms * Time 126 (3.2) 0.5 (0.01) 
Persons * Symptoms * Time + error 8124 (26.2) 32.9 (0.11) 




Model complexity: the number of components 
The generalized scree test initially suggested that the numbers of components for 
the person-, symptom- and time-modes should be set to 3, 3 and 2, respectively 
(3,3,2). However, in this configuration, component scores were not stable across 
imputed datasets. When component stability was considered as an additional 
criterion, a slightly different set of component numbers (3,2,2) was most optimal. 
The fit percentage of this model differed only by 0.50% from that for the (3,3,2) 
model and the (3,2,2) model showed stable components across imputed datasets. 
These considerations led to the selection of a model with three person-mode 
components, two symptom-mode components and two time-mode components. 
The fit percentage of the 3MPCA model  
The averaged fit percentage of the 3MPCA solution across the 20 preprocessed 
imputed datasets was 28% (s.d.= 0.11) and stable, as indicated by the small 
standard deviation. The stability of each of the actual person-, symptom- and time-
mode component structures was inspected by applying a split-half procedure to 
each imputed dataset separately. These analyses showed high congruence (>0.84) 
between components obtained from two random halves of the data, indicating 
good component structure stability.  
The total fit percentage incorporating both the 3MPCA solution and the 
general trend was 65% (s.d.=0.12) across the 20 imputed datasets. Again, the 
small standard deviation suggested that the fit percentage was stable across 
imputed datasets. However, it should be noted that these 28% and 65% fit 
percentages have different meanings since the former is the fit percentage when 
the general trend is removed from the data by preprocessing before fitting the 
3MPCA, while the latter represents the fit when the general trend is not eliminated 
from the data, and thus, also included in the 3MPCA model. Together, these 
results indicated that a considerable part of the total variation in the data could be 
explained by a (3,2,2) 3MPCA model. 
Symptom-mode components 
The averaged component scores for the symptom-mode across the 20 imputed 
datasets are presented in Table 2. Items that assessed, for instance, guilty feelings, 
past failure, self-criticism, self-dislike and body image had high scores on the first 
symptom-mode component, which was labeled the Cognitive component. Items 
with high scores on the second component covered symptoms such as work 
difficulties, tiredness, loss of pleasure, indecisiveness and loss of interest in sex.  
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mean BDI scores decreased considerably at first, stabilizing over time. However, 
there was considerable variability in the individual BDI-score trajectories (see 
Figure 1.B).  
Three-way ANOVA 
Results of the fixed-effects three-way ANOVA, averaged across the 20 imputed 
samples, are presented in Table 1. The highest percentages of explained variance 
were seen for the two-way persons-by-symptoms interaction, the main effect of 
persons and the three-way-interaction-plus-error term. The latter effect had the 
largest contribution indicating the importance of interactions between the person-, 
symptom- and time-modes and underlining the usefulness of fitting a 3MPCA 
model that allows for the modeling of such interactions. Small standard deviations 




Table 1. Three-way Analysis of Variance after subtraction of the grand mean, 
with the patient-, symptom- and time-components as fixed factors. 
Note. SS= Sum of Squares. All effects and standard deviations (s.d.) averaged 
across 20 imputed datasets. 
 
Effect 
Sum of squares 
(s.d.) 
% of explained 
variance (s.d.) 
Persons 4950 (48.5) 20.0 (0.17) 
Symptoms 2296 (17.7) 9.3 (0.07) 
Time 894 (14.1) 3.6 (0.06) 
Persons * Symptoms 6056 (19.2) 24.5 (0.06) 
Persons * Time 2273 (30.4) 9.2 (0.12) 
Symptoms * Time 126 (3.2) 0.5 (0.01) 
Persons * Symptoms * Time + error 8124 (26.2) 32.9 (0.11) 




Model complexity: the number of components 
The generalized scree test initially suggested that the numbers of components for 
the person-, symptom- and time-modes should be set to 3, 3 and 2, respectively 
(3,3,2). However, in this configuration, component scores were not stable across 
imputed datasets. When component stability was considered as an additional 
criterion, a slightly different set of component numbers (3,2,2) was most optimal. 
The fit percentage of this model differed only by 0.50% from that for the (3,3,2) 
model and the (3,2,2) model showed stable components across imputed datasets. 
These considerations led to the selection of a model with three person-mode 
components, two symptom-mode components and two time-mode components. 
The fit percentage of the 3MPCA model  
The averaged fit percentage of the 3MPCA solution across the 20 preprocessed 
imputed datasets was 28% (s.d.= 0.11) and stable, as indicated by the small 
standard deviation. The stability of each of the actual person-, symptom- and time-
mode component structures was inspected by applying a split-half procedure to 
each imputed dataset separately. These analyses showed high congruence (>0.84) 
between components obtained from two random halves of the data, indicating 
good component structure stability.  
The total fit percentage incorporating both the 3MPCA solution and the 
general trend was 65% (s.d.=0.12) across the 20 imputed datasets. Again, the 
small standard deviation suggested that the fit percentage was stable across 
imputed datasets. However, it should be noted that these 28% and 65% fit 
percentages have different meanings since the former is the fit percentage when 
the general trend is removed from the data by preprocessing before fitting the 
3MPCA, while the latter represents the fit when the general trend is not eliminated 
from the data, and thus, also included in the 3MPCA model. Together, these 
results indicated that a considerable part of the total variation in the data could be 
explained by a (3,2,2) 3MPCA model. 
Symptom-mode components 
The averaged component scores for the symptom-mode across the 20 imputed 
datasets are presented in Table 2. Items that assessed, for instance, guilty feelings, 
past failure, self-criticism, self-dislike and body image had high scores on the first 
symptom-mode component, which was labeled the Cognitive component. Items 
with high scores on the second component covered symptoms such as work 
difficulties, tiredness, loss of pleasure, indecisiveness and loss of interest in sex.  
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Table 2. The symptom-mode component scores averaged across 20 imputed data 
sets. 
No Beck Depression Inventory items Cognitive Somatic-affective 
5 Guilty feelings 0.42 -0.03 
3 Past failure 0.40 0.01 
8 Self-criticism 0.40 -0.03 
7 Self-dislike 0.37 0.02 
14 Body image  0.37 -0.04 
6 Feeling punished 0.25 0.05 
9 Suicidal thoughts 0.23 0.12 
1 Sadness 0.22 0.14 
15 Work difficulties -0.08 0.38 
17 Tiredness -0.05 0.36 
4 Loss of pleasure -0.02 0.35 
13 Indecisiveness -0.03 0.35 
21 Loss of interest in sex -0.07 0.30 
12 Loss of interest -0.01 0.29 
11 Agitation -0.05 0.28 
16 Changes in sleeping 0.01 0.24 
10 Crying 0.02 0.22 
2 Pessimism 0.16 0.19 
18 Changes in appetite 0.09 0.15 
20 Somatic preoccupation 0.08 0.15 
19 Changes in weight  0.09 0.05 
Standard deviations (s.d.; computed across 20 imputed datasets) were at most 0.01 
for all loadings. Component scores ≥0.20 are printed in bold font. 
 
Time-mode components 
Table 3 shows the results for the time-mode component. The baseline, 3-month 
and 6-month follow up time-points scored high on the first time-mode component, 
which was labeled the Improving time-component. The 12-month to 24-month 
follow-up time-points scored highest on the second time-mode component. As 
pictured in Figure 1.A, BDI scores stabilized in this phase. Therefore, this 






Table 3. The time-mode component scores averaged across 20 imputed datasets. 
  Improving Persisting 
Baseline 0.73 -0.03 
3M 0.47 0.15 
6M 0.35 0.21 
9M 0.19 0.26 
12M 0.10 0.32 
15M -0.08 0.41 
18M -0.05 0.40 
21M -0.19 0.46 
24M -0.15 0.47 
 
Standard deviations (computed across 20 imputed datasets) were at most 0.03 
across all loadings. The time-mode component scores ≥0.30 are printed in bold 
font. 
 
Core array: the component interactions 
The content of the person-components was derived from the core-array, which 
describes the patterns of interaction between the symptom- and time-components 
in each person-component. The core array elements and the explained variances 
for each combination of components are presented in Table 4, respectively. Most 
variance (13.0%) was explained by the interaction between the somatic-affective 
symptom-component and the persisting time-component in the second person-
component.  The second most variance was explained by the interaction between 
the cognitive symptom-component and persisting time-component in the third 
person-component (4.0%).  
A plot of the sum scores for each of the symptom-mode components over 
time and their average is presented in Figure 1.C and Figure 1.D. The first 
person-mode component was characterized by decreasing scores on both the 
cognitive and somatic-affective components over time and was therefore labeled 
the severe non-persisting depression person-component. The second person-
mode component was characterized by increasing somatic-affective symptom-
component scores and relatively high, but stable cognitive component scores over 
time, and was therefore labeled the somatic depression component. The third 
person-mode component was characterized by high cognitive symptom-
component scores and low somatic-affective symptom,-component scores, which 
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variance (13.0%) was explained by the interaction between the somatic-affective 
symptom-component and the persisting time-component in the second person-
component.  The second most variance was explained by the interaction between 
the cognitive symptom-component and persisting time-component in the third 
person-component (4.0%).  
A plot of the sum scores for each of the symptom-mode components over 
time and their average is presented in Figure 1.C and Figure 1.D. The first 
person-mode component was characterized by decreasing scores on both the 
cognitive and somatic-affective components over time and was therefore labeled 
the severe non-persisting depression person-component. The second person-
mode component was characterized by increasing somatic-affective symptom-
component scores and relatively high, but stable cognitive component scores over 
time, and was therefore labeled the somatic depression component. The third 
person-mode component was characterized by high cognitive symptom-
component scores and low somatic-affective symptom,-component scores, which 
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both remained stable over time. In contrast to the other person-mode components, 
this component was not characterized by any change over time and was therefore 
labeled the cognitive depression component. Compared to the average scores, the 
cognitive depression component had substantially higher cognitive component 
scores over time (see Figure 1.C), while the somatic depression component 
showed substantially higher somatic-affective component scores over time (see 
Figure 1.D). 
 
External correlations of the person-mode components  
The correlations between person-mode components and baseline external 
variables, averaged across 20 imputed datasets, are shown in Table 5. All 
correlations except the ones in parentheses were significant (𝛼𝛼𝛼𝛼 < 0.05) and for 
each person-mode component at least one external correlation exceeded 0.30 in 
absolute sense.  As expected, all person-mode components were positively 
correlated with the depression scale of the SCL-90, but the associations with other 
auxiliary variables varied across person-mode components, indicating 
differentiation in their coverage. The component–specific external correlations 
can be summarized as follows: the severe non-persisting depression component 
was correlated positively with a range of psychopathology measures (e.g. SCL-
90 ‘psycho-neuroticism’, ‘anxiety’ and ‘interpersonal problems’) and was 
negatively correlated with measures of health-related functioning (e.g. MOS-SF-
36 ‘mental health’, ‘vitality’ and ‘social functioning’). The somatic depression 
component also showed positive correlations with psychopathology measures (e.g. 
SCL-90 ‘psycho-neuroticism’ and ‘insufficient thinking’). However, these 
correlations were less pronounced than for the severe non-persisting depression 
component. Moreover, the ‘somatic depression’ component showed a more 
specific pattern of negative correlations with health related functioning (e.g. 
MOS-SF-36 ‘Vitality’, ‘Pain’, ‘Physical functions’ and ‘General health 
perception’), Extraversion and Mastery. The cognitive depression component was 
also characterized by specific external correlations. Of all components, cognitive 
depression showed the strongest positive correlation with Neuroticism and the 
strongest negative correlation with self-esteem. In addition, cognitive depression 
was unrelated to health-related functioning and showed only selective correlations 
with measures of psychopathology (SCL-90 ‘depression’, ‘psycho-neuroticism’ 







Figure. 1. A. Examples of the mean BDI item score trajectories (‘general trend’), B. 
Examples of five patients’ individual BDI trajectories, C. Cognitive symptom-
component plot around the general trend and D. Somatic-affective symptom-
component plot around the general trend for the three person-mode components.  
The two vertical lines in panels 3 and 4 indicate the divisions between the two time-
components (improving and persisting).
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Table 5. Pearson correlations between the person-mode component scores and 
baseline variables. 











Depression 0.60 0.32 0.31 
Psycho-neuroticism 0.58 0.38 0.30 
Insufficiency in 
thinking and acting 
0.55 0.44 0.17 
Somatic complaint 0.50 0.36 0.16 
Anxiety 0.46 0.28 0.21 
Interpersonal sensitivity 
and mistrust 
0.44 0.30 0.34 
Hostility 0.38 0.21 0.25 
Agoraphobia 0.33 0.34 0.19 
Quality of life (MOS-
SF-36) 
Mental health -0.50 -0.30 -0.23 
Vitality -0.48 -0.37 (-0.03) 
Social functions -0.43 -0.32 (-0.03) 
Role functioning-
physical 
-0.40 -0.29 (-0.09) 
Role functioning-
emotional 
-0.39 (-0.13) (0.06) 
Problem with daily 
activity 
0.39 0.22 -0.10 
Pain scale -0.34 -0.33 (-0.08) 
Physical functions -0.32 -0.45 (-0.05) 
Personality and other 
traits 
NEO-FFI neuroticism 0.28 0.33 0.38 
NEO-FFI extraversion -0.25 -0.36 (-0.04) 
Mastery scale -0.28 -0.36 -0.23 
Rosenberg self-esteem -0.35 -0.24 -0.47 
DSM4 Dysthymic 
disorder 
-0.12 0.33 (-0.04) 
SCL-90=Symptoms Checklist-90; MOS-SF36=Medical Outcome Study Short Form 
36; NEO-FFI=Neuroticism, Extraversion, Openness Five-Factor Inventory. All 
correlations had standard deviations (computed across 20 imputed datasets) <0.01. 
Non-significant correlations (p>0.05) are presented in parentheses. Correlation-
coefficients that ≥0.3 in the absolute sense are printed in bold font; correlation 
coefficients ≥0.4 are underlined and printed in bold font. 
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Physical functions -0.32 -0.45 (-0.05) 
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NEO-FFI extraversion -0.25 -0.36 (-0.04) 
Mastery scale -0.28 -0.36 -0.23 
Rosenberg self-esteem -0.35 -0.24 -0.47 
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disorder 
-0.12 0.33 (-0.04) 
SCL-90=Symptoms Checklist-90; MOS-SF36=Medical Outcome Study Short Form 
36; NEO-FFI=Neuroticism, Extraversion, Openness Five-Factor Inventory. All 
correlations had standard deviations (computed across 20 imputed datasets) <0.01. 
Non-significant correlations (p>0.05) are presented in parentheses. Correlation-
coefficients that ≥0.3 in the absolute sense are printed in bold font; correlation 
coefficients ≥0.4 are underlined and printed in bold font. 
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The current study was conceived to investigate the use of 3MPCA to get better 
insight into the heterogeneity of depression. When considered simultaneously in 
3MPCA, depression heterogeneity on the symptom-, person- and time-level could 
be decomposed into 3, 2, and 2 components, respectively. In the symptom-mode, 
cognitive and somatic-affective symptom components were observed. In the time-
mode, an improving and persisting component were observed. Each of the three 
person-components was characterized by different patterns of interaction between 
symptom- and time-component scores. The severe non-persisting depression 
person- component was characterized by the largest improvement in both 
symptom cognitive and somatic-affective scores during the improving and 
persisting phase. The somatic depression person-component was characterized by 
stable symptom-component scores over time, although somatic-affective 
component-scores were much higher than cognitive component-scores. The 
cognitive depression person- component was characterized by stable component 
scores over time, with the cognitive symptom-components being higher than the 
somatic-affective scores. Importantly, a sizable three-way interaction was found 
among the person-, symptom- and time-modes, indicating that heterogeneity in 
each of the modes depends on the heterogeneity in the other modes; something 
that is not accounted for in traditional data-driven approaches. Additional analyses 
showed that each person-mode component was characterized by different patterns 
of correlations with external measures of psychopathology, functioning and 
psychological factors.  
These results have several interesting implications. First of all, they are a 
proof-of-principle for the usefulness of 3MPCA to give more insight in the 
heterogeneity of depression. The eventual person-mode components give an 
intuitive indication of how patient heterogeneity can be reduced by decomposition 
of between-person variance according to how different symptom domains develop 
over time. 3MPCA provides person-mode component scores for each of the 
patients in the study sample, indicating how strongly each of the specific clinical 
pictures applies in a specific person. To translate these scores to clinically useful 
subtypes, the person-mode components could in the future be operationalized into 
valid and reliable measurement scales (e.g. guided by findings such as presented 
in Table 5). Such a measure could be administered to patients and the resulting 
scale-scores could be used to estimate how his/her different symptom-domains 
will develop over time. For instance, if a patient scored highly on the ‘somatic 
depression’ scale and low on the other two component-scales, this patient would 
be likely to benefit the most from interventions that are focused on lasting 




evaluate the appropriateness of such a procedure, measurement instrument and 
the resulting subtyping of patients. Regardless, defining variability amongst 
patients in terms of their specific course patterns on specific symptom domains 
seems like a promising direction for clinical research.      
The current results also have more specific implications. The observed 
decompositions are comparable with, but also extend, the descriptions of 
heterogeneity that have been found with traditional latent variable analyses. The 
finding that the symptom-items of the BDI are explained by a ‘cognitive 
component’ and a ‘somatic-affective component’ is in line with many previous 
studies. A distinction between ‘cognitive’ and ‘somatic’ symptoms has often been 
reported [13, 49-51], and the item loadings on the first two BDI components 
obtained from 3MPCA were very similar to the ones reported elsewhere [13, 52, 
53]. The distinction between cognitive and somatic symptoms does not seem 
specific to the BDI, but has been reported for other instruments: e.g. the Inventory 
of Depressive Symptomatology [54], the Center for Epidemiological Studies 
Depression Scale (CES-D) [13] and the Hamilton Depression Rating Scale [13]. 
The current findings confirm the robustness of this distinction: even when 
heterogeneity across persons and over time is taken into account, similar 
components underlie the heterogeneity of depressive symptomatology. 
Within the time-mode, two time-phase components were identified: an 
improving phase (from baseline to 6 months) and a persisting phase (12 months 
to 24 months). This subdivision reflects the particular temporal dynamic of 
symptomatology in the current sample, composed of patients that met MDD 
criteria at baseline, received treatment, and recovered over time. The results imply 
a tipping point in the range between 6 months and 12 months and provide some 
insight into the time that is typically needed to go from increased BDI scores to a 
point where the scores reach their minimum values. With regard to categorically 
determined depression, the definition of when someone reaches a state of 
remission is still a matter of debate [33, 55-57]. The current purely data-driven 
results suggest that the point of transition is reached between 6 and 12 months. 
This change seems to progress gradually over a period of 6 months, suggesting 
that it is probably futile to pinpoint a single cut-off time for remission. This is 
further illustrated by the lack of any discernible cut-off in the upper panels of 
Figure 1.   
The person-mode components provide insight into the heterogeneity on 
the person mode, defined in terms of symptom-mode and time-mode 
combinations. The severe non-persisting depression component was characterized 
by a relatively favorable clinical picture. Although initially characterized by high 
severity on both symptom-domains (as also reflected in the correlations with 
baseline variables), the component was characterized by a quick decrease in 
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the resulting subtyping of patients. Regardless, defining variability amongst 
patients in terms of their specific course patterns on specific symptom domains 
seems like a promising direction for clinical research.      
The current results also have more specific implications. The observed 
decompositions are comparable with, but also extend, the descriptions of 
heterogeneity that have been found with traditional latent variable analyses. The 
finding that the symptom-items of the BDI are explained by a ‘cognitive 
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heterogeneity across persons and over time is taken into account, similar 
components underlie the heterogeneity of depressive symptomatology. 
Within the time-mode, two time-phase components were identified: an 
improving phase (from baseline to 6 months) and a persisting phase (12 months 
to 24 months). This subdivision reflects the particular temporal dynamic of 
symptomatology in the current sample, composed of patients that met MDD 
criteria at baseline, received treatment, and recovered over time. The results imply 
a tipping point in the range between 6 months and 12 months and provide some 
insight into the time that is typically needed to go from increased BDI scores to a 
point where the scores reach their minimum values. With regard to categorically 
determined depression, the definition of when someone reaches a state of 
remission is still a matter of debate [33, 55-57]. The current purely data-driven 
results suggest that the point of transition is reached between 6 and 12 months. 
This change seems to progress gradually over a period of 6 months, suggesting 
that it is probably futile to pinpoint a single cut-off time for remission. This is 
further illustrated by the lack of any discernible cut-off in the upper panels of 
Figure 1.   
The person-mode components provide insight into the heterogeneity on 
the person mode, defined in terms of symptom-mode and time-mode 
combinations. The severe non-persisting depression component was characterized 
by a relatively favorable clinical picture. Although initially characterized by high 
severity on both symptom-domains (as also reflected in the correlations with 
baseline variables), the component was characterized by a quick decrease in 
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severity after baseline and the lowest severity levels after two years. The somatic 
depression component was characterized by a less favorable course with more 
persistent levels of somatic affective and decreasing cognitive symptomatology. 
The cognitive depression component was characterized by higher levels of 
cognitive symptomatology than somatic-affective symptomatology over time. 
The differentiation between these components was further clarified by the 
differential patterns of correlation with baseline external variables, indicating that 
the person-mode components could be regarded as distinct clinical entities within 
depression.  
Two types of the 3MPCA fit percentages (28% and 65%) were consistent 
across 20 imputed datasets as observed for the small standard deviations. The 
difference between these fit percentages can be explained by the fact that most 
patients followed a similar downward trend in severity over time (Figure 1.A), 
but also showed varying patterns of fluctuation around this general trend (Figure 
1.B). 
The present study had several strengths. First, the longitudinal data with 
its large number of measurements was ideal for the current research aims. Second, 
stability of the component structures was evaluated with split-half procedures, 
lending internal support for their generalizability. However, some limitations 
should also be considered. First, the generalization of the current results is limited 
to outpatient samples. Second, the 65% fit indicates that 35% was still not able to 
be captured by the 3MPCA model. This is likely to be due to the considerable 
measurement error that is inherent to self-report measures such as the BDI. Third, 
there is no available oblique rotation technique which obtains simple structure in 
the core array as well as some of the component matrices simultaneously in all 
three modes. Therefore, orthogonal rotation (Orthomax rotation) was applied in 
the current analysis, although the assumptions of uncorrelated components for 
each mode may be too strict to do justice to the real nature of psychopathology. 
Fourth, although correlations with external variables were investigated, a true 
independent external validation could not be conducted in the current study and, 
thus, needs to be done in the future. Fifth, the presented results apply to depression 
data collected with the BDI, which is not exhaustive in its coverage of depression 
symptomatology. In future work, the studied item-pool could be extended with 
items from other instruments to develop models that explain a broader range of 
symptoms. 
In conclusion, 3MPCA offers an insightful longitudinal description of 
how depression can be decomposed into more homogenous entities. These results 
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Appendix A. Inclusion procedure. 
Detailed inclusion procedure 
Of the 267 patients, 219 were included in the three-mode Principal Component 
Analysis (3MPCA). Forty-eight patients were excluded because they missed BDI 
data on more than 5 out of the 9 measurement time points. This inclusion criterion 
was chosen (1) to retain the sample size and (2) to avoid bias in the multiple 
imputation model. Figure A1.1 shows the number of subjects (y-axis) for each 
total number of missing items (x-axis). It can be seen from the figure that 113 
patients did not have missing data in two-year study period (the most left) and one 
patient did not answer any BDI items over the study period (the most right). 
 
Figure A1.1: The histogram for the number of subjects and the number of 
missing items in total (21 items x 9 time points) 
The number of patients with different numbers of completed BDI measurements 
during the study period is summarized in Table A1.1. If a patient responded to at least 
one BDI item, a measurement was considered complete and suitable for imputation.  
 
Table A1.1: the number of patients and the number of time points participated 
Number of measurements 
completed 
0 1 2 3 4 5 6 7 8 9 
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Appendix A. Inclusion procedure. 
Detailed inclusion procedure 
Of the 267 patients, 219 were included in the three-mode Principal Component 
Analysis (3MPCA). Forty-eight patients were excluded because they missed BDI 
data on more than 5 out of the 9 measurement time points. This inclusion criterion 
was chosen (1) to retain the sample size and (2) to avoid bias in the multiple 
imputation model. Figure A1.1 shows the number of subjects (y-axis) for each 
total number of missing items (x-axis). It can be seen from the figure that 113 
patients did not have missing data in two-year study period (the most left) and one 
patient did not answer any BDI items over the study period (the most right). 
 
Figure A1.1: The histogram for the number of subjects and the number of 
missing items in total (21 items x 9 time points) 
The number of patients with different numbers of completed BDI measurements 
during the study period is summarized in Table A1.1. If a patient responded to at least 
one BDI item, a measurement was considered complete and suitable for imputation.  
 
Table A1.1: the number of patients and the number of time points participated 
Number of measurements 
completed 
0 1 2 3 4 5 6 7 8 9 
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The baseline characteristics of the total sample and the selected study group are 
summarized in Table A1.2.  
 
 
Table A1.2:  Baseline characteristics of the subgroups of the dataset 
 
  










N 267 219 113 
Female (%) 171 (64.0%) 144 (65.8%) 70 (61.9%) 
Mean years of age (SD) 42.8 (11.3) 43.3 (11.1) 43.0 (11.2) 
Age range 17-69 17-69 17-69 
Psychiatric characteristics (SCL-90)    
Mean sum score of depression scale (SD)  





Mean sum score of anxiety scale (SD) 
22.0 (8.0)    
[9] 
21.8 (7.8)   
[3] 
20.8 (7.3) 
Mean sum score of psycho neuroticism scale (SD) 
196 (55.5)   
[11] 
195 (54.5)  
[3] 
188 (50.7) 
Mean BDI sum score (SD) 
19.5 (9.1)    
[38] 
19.4 (9.1)   
[26] 
19.1 (9.1) 
SD = standard deviation, BDI = Beck Depression Inventory, SCL-90 = Symptom Checklist-
90.  
Note that the calculation of psychiatric characteristics and mean BDI sum scores were done 
by eliminating the patients with missing data (listwise deletion). The numbers of patients not 






Appendix B. Imputation procedure 
3MPCA cannot be performed with missing data. Therefore, an imputation procedure 
was required. In our analysis, multiple imputation was performed by generating 20 
imputed datasets. All the analyses (three-way ANOVA, 3MPCA) were performed for 
each of the 20 imputed datasets.  
Using two criteria described below, auxiliary variables were selected to be 
included in the multiple imputation model besides the BDI scores: 
1) Variables which are significantly (𝑝𝑝𝑝𝑝 < 0.01) and strongly (correlations larger than 
0.3 in absolute sense) correlated with the BDI scores. 
 2) Variables which are significantly (𝑝𝑝𝑝𝑝 < 0.01) and strongly (correlations larger than 
0.3 in absolute sense) correlated with the missingness of the BDI scores. 
In total, 1392 auxiliary variables satisfied both abovementioned criteria. 
However, when we included all these variables in the multiple imputation program 
(AMELIA II in RStudio), the program did not converge due to working memory 
restrictions of the used computer hardware. Therefore, further selection of the 
auxiliary variables was required.  
The 1392 auxiliary variables satisfying both abovementioned criteria can be 
classified into four groups according to the time they were measured. The black bars 
in Figure B.1 indicate the variables were measured and summarized below. 
 ‘BDI’: the BDI items measured trimonthly during the two-year 
study period (analyzed data in the current study).  
 ‘aux.1’: the auxiliary variables measured only at baseline.  
 ‘aux.2’: the weekly scores of the variables obtained in a 
retrospective manner. For these variables, the patients were 
interviewed every three months and the presence of the  nine DSM-
IV criterion symptoms of major depressive disorder were assessed 
for each of the twelve preceding weeks, resulting in two years’ 
worth of weekly depression scores (range: 0-9; detailed information 
in Conradi et al., 2012).  
 ‘aux.3’ represents the auxiliary variables measured up to 36 month 
follow-up 
 ‘aux.4’ represents the variables measured only at the 36 months 
follow-up. However, it should be noted that due to limited funds, 
variables belong to ‘aux.3’ and ‘aux.4’ were not administered in all 
participants.
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Appendix C. Data preprocessing procedure  
1. Centering across person-mode  
For the present data, we assumed a ‘neutral point’ or ‘natural zero’ for each 
response scale which was unknown and may have differed for each scale 
(centering across person-mode). For example, suppose we have 4x3x2 array 
which consists of 4 persons’ answers to 3 items (item A, B and C) at 2 time points 
(Measure 1 and 2) as shown below (Table C.1): 
 
Table C.1: Example data  
Time point Measure 1 Measure 2 
Item A B C A B C 
Person 1 1 3 2 2 1 1 
Person 2 1 1 2 0 1 3 
Person 3 2 2 1 1 0 2 
Person 4 0 3 2 0 0 2 
Mean 1 2.25 1.75 0.75 0.5 2 
 
The centered data is obtained by subtracting the mean score (neutral point) of each 
item on each time point from the original data (illustrated in Table C.2): 
 
Table C.2: Illustration of the centering procedure  
Time point Measure 1 Measure 2 
Item A B C A B C 
Person 1 0 0.75 0.25 1.25 0.5 -1 
Person 2 0 -1.3 0.25 -0.8 0.5 1 
Person 3 1 -0.3 -0.8 0.25 -0.5 0 
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2. Normalization within symptom-mode 
Suppose I=number of persons, J=number of items, K=number of time points (with the 
current example, I=4, J=3, K=2). Then normalizing within symptom-mode means to 




























= 0.59 .  
Finally, the preprocessed data (centered across person-mode and normalized within 
symptom-mode data) will look as shown below (Table C.3). 
 
Table C.3: Illustration of the centering and normalization procedure 
Time point Measure 1 Measure 2 
Item A B C A B C 
Person 1 0 1.09 0.43 1.62 0.73 -1.71 
Person 2 0 -1.83 0.43 -0.97 0.73 1.71 
Person 3 1.3 -0.37 -1.28 0.32 -0.73 0 
Person 4 -1.3 1.1 0.43 -0.97 -0.73 0 
 
Note that after normalizing the data, each item has variance 1 over the 8 observations.  
 
As described in the Methods section, the preprocessing procedure (centering and 
normalizing) is required since 3MPCA consists of multiplications of components and 
the core array, which implicitly implies that the data are treated as ratio scales. By 
centering across person-mode, the item mean scores for each time point will be treated 
as a ‘neutral point’. As a result, centering across person-mode eliminates the ‘general 
trend’ from the dataset, since patients who scored the item mean scores will be treated 





Appendix D. Interpretation of the fit percentages. 
The preprocessing procedure eliminates the ‘general trend’. Therefore, in order to 
calculate the fit percentage of the 3MPCA model and the general trend combined, the 
effects of the preprocessing procedure have to be artificially reversed. The Matlab 
code to calculate fit percentage by incorporating ‘general trend’ together with the fit 
of 3MPCA procedure can be obtained from the author (r.tendeiro-monden@umcg.nl). 
Here, the calculation of the fit percentage, which incorporates the ‘average trend’ is 
described briefly.  
 
The estimated array obtained from the 3MPCA result was rescaled by multiplying the 




 with I=number of 
persons, J=number of items, K=number of time points. In addition, mean scores of 
each item on each time point was added to the rescaled estimated array. Finally, the 
fit percentage of the of the 3MPCA and the general trend combined was calculated by  
(𝑿𝑿𝑿𝑿 − ?̃?𝑿𝑿𝑿)
2
/𝑿𝑿𝑿𝑿2, where 𝑿𝑿𝑿𝑿 is the original data and ?̃?𝑿𝑿𝑿 is the estimated array by 3MPCA.
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